RecruitingNCT06355414
Psilocybin or methylphenidate for chronic back pain and depression
About this title
Read the official source — NCT06355414Medication studyAges 21–80United States
Understand this study
Who could participate?
Listed age limits: 21 years to 80 years.
What will I do during this study?
Participants are randomly assigned to one supported drug session with psilocybin or methylphenidate. The record describes screening, assessments before and after the session, follow-up visits up to one month later, and repeated surveys through an app during participation.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 22, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 80 Years
- Official registry ID
- NCT06355414
- Official title
Show the full official title
Psilocybin and Affective Function in Chronic Lower Back Pain Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin and Methylphenidate.
Who can participate?
Listed age limits: 21 years to 80 years.
Is this study still recruiting?
The registry lists this study as recruiting.
